by Lisa Blum | Feb 24, 2020
The project ImmUniverse has been formed as a European transdisciplinary consortium to tackle these unmet needs and to understand the role of the crosstalk between tissue microenvironment and immune cells in disease progression and response to...
by Lisa Blum | Dec 2, 2019
The vision of Immune Safety Avatar (imSAVAR) is to develop a platform for integrated nonclinical assessments of immunomodulatory therapy safety and efficacy. Existing nonclinical models do not adequately represent the complexity of the immune system and its...
by Lisa Blum | Oct 15, 2019
ITTM was certified in 2019 as one of the very first SMEs by the IMI EHDEN and since the is part of the EHDEN SME marketplace: https://www.ehden.eu/business-directory/ITTM offers services aroundOHDSI Software and Tools: Installation of the analytical infrastructure,...
by Lisa Blum | Apr 1, 2019
BIOMAP objective is to provide a taxonomic and predictive systems medicine model of Atopic Dermatitis and Psoriasis based on clinical and molecular profiling to identify determinants of clinically relevant outcomes (disease manifestation, progression, comorbidity...
by Lisa Blum | Mar 11, 2019
Innovative scientific approaches have facilitated significant progress in drug development during recent decades, offering amazing new treatment options to patients across a range of chronic diseases. However, safety and tolerability of drug candidates and newly...
